INTERFERON α-2B BY CONTINUOUS SUBCUTANEOUS INFUSION IN COMBINATION WITH RIBAVIRIN FOR TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS: 12 WEEK INTERIM ANALYSIS

被引：0
|
作者：
Muir, Andrew J. [1 ]
Bacon, Bruce R. [2 ]
Gitlin, Norman [4 ]
Kugelmas, Marcelo [3 ]
Tillman, Hans L. [1 ]
Grovender, Eric A. [5 ]
Van Antwerp, Bill [5 ]
Mische, Sarah [5 ]
Kwo, Paul Y. [6 ]
机构：
[1] Duke Clin Res Inst, Durham, NC USA
[2] St Louis Univ, Sch Med, St Louis, MO USA
[3] S Denver Gastroenterol, Englewood, CO USA
[4] Atlanta Gastroenterol Associates, Atlanta, GA USA
[5] Medtronic, Ventures & New Therapies, Minneapolis, MN USA
[6] Indiana Univ Sch Med, Indianapolis, IN USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1439A / 1439A
页数：1
相关论文
共 50 条
  • [1] Comparison of ribavirin with PEG-interferon α-2a or with α-2b in treatment-naive patients
    Webb, Amy
    Poy, Isela
    Patel, Rikin
    Ali, Olga
    Page, Robert
    Kashi, Maryam
    Herrera, Ana
    Schoolfield, John
    Brock, Paul
    Hoyumpa, Anastacio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S181 - S182
  • [2] Phase 2b study of the interferon-free and ribavirin-free combination of daclatasvir, asunaprevir, and BMS-791325 for 12 weeks in treatment-naive patients with chronic HCV genotype 1 infection Abstracts
    Everson, Gregory T.
    Sims, Karen D.
    Thuluvath, Paul J.
    Lawitz, Eric
    Hassanein, Tarek
    Rodriguez-Torres, Maribel
    Hawkins, Trevor
    Schwartz, Howard
    Rustgi, Vinod K.
    Hinestrosa, Federico
    Levin, James M.
    Younossi, Zobair M.
    Webster, Lynn R.
    Eley, Timothy
    Huang, Shu-Pang
    McPhee, Fiona
    Grasela, Dennis M.
    Gardiner, David F.
    HEPATOLOGY, 2013, 58 (06) : 1377A - 1377A
  • [3] INTERFERON-FREE TREATMENT WITH A COMBINATION OF MERICITABINE AND DANOPREVIR/R WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED PATIENTS
    Gane, E. J.
    Pockros, P.
    Zeuzem, S.
    Marcellin, P.
    Shikhman, A.
    Bernaards, C.
    Yetzer, E. S.
    Shulman, N.
    Tong, X.
    Najera, I.
    Bertasso, A.
    Hammond, J.
    Stancic, S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S555 - S556
  • [4] Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3
    Mangia, Alessandra
    Bandiera, Franco
    Montalto, Giuseppe
    Mottola, Leonardo
    Piazzolla, Valeria
    Minerva, Nicola
    Pellicelli, Adriano
    Ricci, Giovanni L.
    Cela, Marina
    Carretta, Vito
    Scotto, Gaetano
    Bacca, Donato
    Annicchiarico, Brigida
    Romano, Mario
    Russello, Maurizio
    Barbarini, Giorgio
    Agostinacchio, Ernesto
    Andriulli, Angelo
    JOURNAL OF HEPATOLOGY, 2010, 53 (06) : 1000 - 1005
  • [5] VX-222/TELAPREVIR IN COMBINATION WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS TREATED FOR 12 WEEKS: ZENITH STUDY, SVR12 INTERIM ANALYSIS
    Nelson, David R.
    Gane, Edward J.
    Jacobson, Ira M.
    Di Bisceglie, Adrian M.
    Alves, Katia
    Koziel, Margaret J.
    De Souza, Cynthia
    Kieffer, Tara L.
    George, Shelley
    Rosario, Maria
    Kauffman, Robert S.
    Sulkowski, Mark S.
    HEPATOLOGY, 2011, 54 : 1435A - 1435A
  • [6] Pegylated IFN-α2b plus ribavirin for treatment-naive patients coinfected with HCV and HIV
    Mallolas, Josep
    Laguno, Montserrat
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (03) : 281 - 289
  • [7] Phase 2b interim (week 12) results of albumin interferon alpha-2b combined with ribavirin in IFN-naive, genotype 1 chronic hepatitis C infection
    Benhamou, Y.
    Zeuzem, S.
    Shouval, D.
    Bain, V.
    Pianko, S.
    Flisiak, R.
    Grigorescu, M.
    Rehak, V.
    Yoshida, E.
    Kaita, K.
    Hezode, C.
    Neumann, A. U.
    Subramanian, M.
    McHutchison, J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S38 - S39
  • [8] Consensus interferon in combination with gamma interferon and/or ribavirin leads to a significant response in treatment-naive hepatitis C genotype 1 patients
    Kaiser, S
    Hass, H
    Gregor, M
    HEPATOLOGY, 2005, 42 (04) : 277A - 277A
  • [9] EFFICACY AND SAFETY OF TMC435 IN COMBINATION WITH PEGINTERFERON α-2A AND RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 HCV PATIENTS: 24-WEEK INTERIM RESULTS FROM THE PILLAR STUDY
    Fried, Michael W.
    Buti, Maria
    Dore, Gregory J.
    Ferenci, Peter
    Jacobson, Ira
    Marcellin, Patrick
    Zeuzem, Stefan
    Lenz, Oliver
    Peeters, Monika
    Sekar, Vanitha J.
    De Smedt, Goedele
    HEPATOLOGY, 2010, 52 (04) : 403A - 404A
  • [10] Continuous interferon-α2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients
    Roomer, Robert
    Bergmann, Jilling F.
    Boonstra, Andre
    Hansen, Bettina E.
    Haagmans, Bart L.
    Kwadijk-de Gijsel, Sonja
    van Vuuren, Anneke J.
    de Knegt, Robert J.
    Janssen, Harry L. A.
    ANTIVIRAL THERAPY, 2012, 17 (03) : 509 - 517
12345